• Roche in Deutschland
Header-Bild

34th European Congress of Clinical Microbiology & Infectious Diseases

27-30 April 2024

Barcelona, Spain

Choosing your own adventure! Shining a light on the best utilization of syndromic testing and its application to respiratory infections.

There are many syndromes caused by infectious diseases in today's world, and one of the greatest tools that we all have to diagnose, appropriately treat, and manage challenging infections, is molecular syndromic testing. Join our presenters to explore the multifaceted landscape of respiratory testing, offering insights on how to effectively apply diverse testing modalities to enhance patient care and streamline laboratory operations.

sambri

Vittorio Sambri
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum-University of Bologna

1st Talk (25 min)
Exploring the status quo and unmet medical needs for syndromic testing

berger

Annemarie Berger
Institute of Medical Virology, University Hospital Frankfurt, Goethe University

2nd Talk (20 min)
Utility of rapid, precise and easy to use solution in a near patient setting

eigner

Ulrich Eigner
MVZ Laboratory Dr. Limbach

3rd Talk (20 min)
Hands-on experience and benefits of an automated laboratory based high throughput solution

Where Are We with STI POC Testing?
vdp

Barbara Van der Pol
Dr. Van der Pol's talk will introduce ECCMID attendees to the importance of testing for STIs, the gold standard for bacterial STI testing and the evidence discussing the clinical utility of molecular point of care STI testing.

Trichomonas vaginalis and Mycoplasma genitalium prevalence in Europe
garcia

Federico Garcia
Dr. Garcia will discuss the results of a Roche sponsored study that looked at the prevalence of Trichomonas vaginalis and Mycoplasma genitalium in patient populations across several European countries. It will introduce attendees to the importance of testing for these neglected STIs, and increase understanding of which patient populations are most vulnerable to these infections.